Charles Schwab Investment Management Inc Amicus Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,326,927 shares of FOLD stock, worth $22.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,326,927
Previous 2,268,886
2.56%
Holding current value
$22.9 Million
Previous $32.2 Million
14.86%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding FOLD
# of Institutions
273Shares Held
325MCall Options Held
841KPut Options Held
353K-
Vanguard Group Inc Valley Forge, PA28.2MShares$278 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$276 Million6.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$270 Million3.89% of portfolio
-
Black Rock Inc. New York, NY22.8MShares$225 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA18.8MShares$185 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.76B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...